Guest blog: Patents in the biopesticide industry revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Guest blog: Patents in the biopesticide industry revealed

Who is applying for patents in the biopesticide industry? Rubal Walia of INDUS TechInnovations explains

Although synthetic chemical fertilizers occupy a large share of pesticide market, biopesticides are gradually gaining significance. We have been looking at the patent landscape as well as the trends and patterns emerging in the Biopesticide industry.

We studied the patent filings in this technology area to understand the investments and patenting efforts being made. The infographic below outlines some interesting trends such as the pace of progress over the last decade, the geographical distribution of patents, patent transactions between different organisations and top patent asset holders.

The report displays a steady increase in published patents over the years, with 2012 revealing a sharp rise. Geographically, the US and China have dominated this area in patents and applications, followed by Europe. In addition, Monsanto, one of the pioneers in developing genetically modified seeds, leads the race as the top patent asset holder, with more than 1,400 patents. Pioneer, a Dupont company, is close behind with more than 1,000 patents.

The report also indicates that Monsanto is among the top acquirers of patents, buying patents from companies such as D&PL Technologies, Pharmacia, and Ecogen. Rivals Bayer and Gibraltar Business Capital have also acquired a large number of patents. You can see more information in the graphic.

Image The infographic was produced by Relecura, a patent and portfolio analysis platform developed by INDUS TechInnovations.

more from across site and SHARED ros bottom lb

More from across our site

Judge Alan Albright is to leave his role at the Western District of Texas, and could return to private practice
Stobbs has successfully seen off a contempt of court application filed against the firm and two of its lawyers
After almost a quarter of a century, Marshall Gerstein has a new managing partner
Abbott winning another round against Sinocare and Menarini, and 'long arm' clarification on the UK's position within the UPC, were also among major developments
Maria Peyman, head of IP at Birketts, explains why the firm is adopting a ‘seamless approach’ for clients by integrating two of its practice areas
Matthew Swinn, who leads the firm’s IP practice, discusses why Mallesons is well-placed to remain a major IP force
Lawyers at A&O Shearman analyse developments regarding UPC’s long-arm jurisdiction, including its scope and jurisdictional limits
Michelle Lee discusses reaching milestones at the USPTO, AI’s role in legal work, and how to empower women in tech and IP
Executive chair Matt Dixon, who reveals a new associate hire, says the firm wants to offer a realistic pathway to partnership while avoiding the ‘corporate machine’ route
Mayer Brown’s role in cardiovascular technology dispute reflects how firms are pursuing precedent-setting cases to try and guide AI and patent law
Gift this article